Study from ACC meeting shows those undergoing CAC screening to be twice as adherent as those receiving PCERS screen
By: Renee Cocchi | 10/14/2020
Clinical Advisor: Gerrie Gardner, DO, Monique Lucarelli, MD
Quick reads and recommendations
Evolocumab reduced the risk of VTE, and this effect was more pronounced in patients with elevated baseline lipoprotein(a) levels Read More...
By David Modrak, PhD | 08/13/2025
Clinical Advisor: Monique Lucarelli, MD
Study from ACC meeting shows those undergoing CAC screening to be twice as adherent as those receiving PCERS screen Read More...
By Renee Cocchi | 08/13/2025
As more enrollees seek care, keep in mind that they might have a backlog of required preventive care services. Here’s what to do...and not do. Read More...
By Renee Cocchi | 07/08/2025
What to do...and why
AMERICAN COLLEGE OF CARDIOLOGY Read More...
By Gayle Scott, PharmD | 08/13/2025
Clinical Advisor: Gerrie Gardner, DO
We provide essential recommendations, and our clinical advisor urges caution regarding several of the suggested diagnostic tests Read More...
By Neeta O’Mara, PharmD | 08/13/2025
Clinical Advisor: David Shein, MD
Recommendation has been updated to include edoxaban, a new factor Xa inhibitor Read More...
Listen and learn CME
10/29/2020 | Preventive Care